ervaccinetechnologies.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:
Meta Tags
Title home - ErVaccine
Description ErVaccine Technologies Announces Inaugural Members of Scientific Advisory https://www.ervaccinetechnologies.com/wp-content/uploads/2021/11/ervaccine.jpg
Keywords N/A
Server Information
WebSite ervaccinetechnologies faviconervaccinetechnologies.com
Host IP 81.88.52.226
Location Italy
Related Websites
Site Rank
More to Explore
ervaccinetechnologies.com Valuation
US$261,614
Last updated: 2023-05-18 03:06:59

ervaccinetechnologies.com has Semrush global rank of 40,457,745. ervaccinetechnologies.com has an estimated worth of US$ 261,614, based on its estimated Ads revenue. ervaccinetechnologies.com receives approximately 30,187 unique visitors each day. Its web server is located in Italy, with IP address 81.88.52.226. According to SiteAdvisor, ervaccinetechnologies.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$261,614
Daily Ads Revenue US$242
Monthly Ads Revenue US$7,245
Yearly Ads Revenue US$86,937
Daily Unique Visitors 2,013
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
ervaccinetechnologies.com. 900 A ervaccinetechnologies.com. 900 IP: 81.88.52.226
ervaccinetechnologies.com. 900 NS ervaccinetechnologies.com. 900 NS Record: ns2.amenworld.com.
ervaccinetechnologies.com. 900 NS ervaccinetechnologies.com. 900 NS Record: ns1.amenworld.com.
ervaccinetechnologies.com. 900 MX ervaccinetechnologies.com. 900 MX Record: 10 mail-fr.securemail.pro.
ervaccinetechnologies.com. 900 TXT ervaccinetechnologies.com. 900 TXT Record: v=spf1 include:spf.webapps.net ~all
HtmlToTextCheckTime:2023-05-18 03:06:59
About us Science Investors News Join us Contact us Targeting non-conventional antigens to reshape tumor immunity Learn More home charles 2021-12-19T14:53:48+00:00 Vision & Mission Combining cancer vaccines and T-cell therapies ErVaccine Technologies develops breakthrough immunotherapies combining cancer vaccines and T-cell therapies based on the identification of new families of tumor antigens. We are dedicated to discover more accurate tumor epitopes that are shared between patients. We focus on non-conventional epitopes derived from endogenous retroviruses (HERVs). Our approach is based on new bioinformatics algorithms to identify potential epitopes that are validated by proteomics and immunology assays: from bioinformatics to proteomics. About us Latest News Published On: February 23rd, 2023 ErVaccine Technologies Announces Inaugural Members of Scientific Advisory Board Download the press release Lyon, France – February 23, 2023 – ErVaccine Technologies, a French biotech company
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Tue, 10 May 2022 08:39:42 GMT
Server: Apache
X-Powered-By: PHP/7.4.27
X-Redirect-By: WordPress
Upgrade: h2,h2c
Connection: Upgrade
Location: https://www.ervaccinetechnologies.com/
Vary: User-Agent
Content-Type: text/html; charset=UTF-8

HTTP/2 200 
x-powered-by: PHP/7.4.27
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
vary: User-Agent
content-type: text/html; charset=UTF-8
date: Tue, 10 May 2022 08:39:45 GMT
server: Apache
ervaccinetechnologies.com Whois Information
Domain Name: ERVACCINETECHNOLOGIES.COM
Registry Domain ID: 2586385911_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.register.it
Registrar URL: http://www.register.it
Updated Date: 2022-01-23T08:16:18Z
Creation Date: 2021-01-22T14:06:02Z
Registry Expiry Date: 2023-01-22T14:06:02Z
Registrar: Register SPA
Registrar IANA ID: 168
Registrar Abuse Contact Email: abuse@register.it
Registrar Abuse Contact Phone: +39.05520021555
Domain Status: ok https://icann.org/epp#ok
Name Server: NS1.AMENWORLD.COM
Name Server: NS2.AMENWORLD.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-05-10T10:00:36Z <<<

Copyright © 2022 WebZZ.US 0.0216